Brazil Coronary Stents Market Report 2022 to 2030

Brazil Coronary Stents Market Analysis

$ 3999

Brazil's Coronary Stents Market is expected to grow from $283 Mn in 2022 to $442 Mn in 2030 with a CAGR of 5.75% for the forecasted year 2022-30. Brazil has high rates of CAD incidence and prevalence, which raises serious public health concerns. As a result, there is an increasing need for coronary stents as a CAD treatment option, which is propelling market expansion. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include: Nipro Medical do Brasil Ltda, Arthrocare do Brasil Ltda, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, and Philips Healthcare.

ID: IN10BRMD006 CATEGORY: Medical Devices GEOGRAPHY: Brazil AUTHOR: Jigyasu Bhandari

Buy Now

Brazil Coronary Stents Healthcare Market Executive Analysis

Brazil's Coronary Stents Market is expected to grow from $283 Mn in 2022 to $442 Mn in 2030 with a CAGR of 5.75% for the forecasted year 2022-30. Brazilian government spending on current health increased from 9.46% in 2018 to 9.59% in 2019 (as a percentage of GDP). Brazil's GDP will be allocated to healthcare by 2040 at a rate of 12.6%, with room for growth in areas like primary care, hospital care, pharmaceuticals, long-term care, and administration. Brazilian men and women may expect to live 72.5 and 79.5 years, respectively. The annual population growth in Brazil is 0.7%.

Brazil's main cause of death, accounting for 17.7% of all fatalities there, was coronary artery disease. Coronary stents are tiny, mesh-like tubes made of metal or plastic that are used to relieve coronary artery blockages, which can result in chest pain and raise the risk of having a heart attack. Coronary stents work to maintain the artery open, lower the risk of a heart attack, and relieve symptoms like chest pain in the heart muscle. With a catheter commonly placed by a small incision in the groin or wrist, the operation to place a coronary stent is minimally invasive, which can lower the risk of problems and hasten recovery. In comparison to open heart surgery, individuals who undergo minimally invasive treatment frequently experience shorter hospital stays and quicker recovery times. Coronary stents are frequently a long-term therapy option that eliminates the need for additional operations like angioplasty or coronary artery bypass surgery. Coronary stents are available in a range of diameters and forms, enabling medical professionals to tailor treatment to the unique requirements of each patient.

Brazil Coronary Stents Market Analysis

Market Dynamics

Market Growth Drivers

Brazil has high rates of CAD incidence and prevalence, which raises serious public health concerns. As a result, there is an increasing need for coronary stents as a CAD treatment option, which is propelling market expansion. Typically, coronary stents are placed by minimally invasive techniques, which provide a number of benefits over open heart surgery. The demand for coronary stents is rising along with the popularity of these procedures in Brazil. Technology developments have increased the safety and effectiveness of coronary stents, which has increased demand for these devices in Brazil. One such advance is the creation of drug-eluting stents. Brazil's population is getting older quickly, making it more susceptible to CAD and other cardiovascular conditions. Demand for coronary stents is anticipated to rise as a result.

Market Restraints

In Brazil, coronary stents can be expensive, which may make them less accessible to patients. This puts manufacturers at a disadvantage because patients in the public healthcare system could not have access to the newest and most cutting-edge stents. Although bypass surgery and pharmaceutical therapy are other options for treating CAD, coronary stents are a useful first line of treatment. The expansion of the coronary stents market in Brazil may be constrained by competition from these alternatives. Brazilian reimbursement regulations for coronary stents may not fully cover the cost of the devices, posing financial difficulties for patients and medical professionals.

Competitive Landscape

Key Players

Nipro Medical do Brasil Ltda (BR)
Arthrocare do Brasil Ltda (BR)
Biotronik
Boston Scientific
B. Braun
Abbott Laboratories
GE Healthcare
Medtronic
Philipps Healthcare

Healthcare Policies and Regulatory Landscape

The Brazilian Health Regulatory Agency (ANVISA) and the Ministry of Health are in charge of regulating the healthcare system and the landscape for coronary stents in Brazil. The regulatory framework is intended to guarantee the safety and efficacy of medical devices, particularly coronary stents, for use in Brazil. ANVISA certification is required for manufacturers to market a coronary stent in Brazil. To prove the device's safety and effectiveness, a variety of technical and clinical data must be submitted. If the equipment is found to comply with Brazilian regulatory criteria, ANVISA examines these data and issues a registration certificate. The Brazilian government is aiming to increase public sector access to medical equipment and other healthcare services. The More Doctors Programme (PMM) and the National Health Plan (PNS) are two programmes focused on enhancing the Brazilian population's access to and quality of healthcare.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Coronary Stents Market Segmentation

By Type (Revenue, USD Billion):

The three main categories of coronary stents are bare-metal, drug-eluting, and bioabsorbable, depending on their nature. The segment for bioabsorbable stents is anticipated to increase at the fastest rate over the forecast period. The benefits that are encouraging the use of bioabsorbable stents include a decrease in problems including thrombosis and inflammation, the cBrazility to restore normal vasomotion, and an improvement in aberrant endothelial function. However, in the upcoming years, the expansion of this market segment is anticipated to be constrained by the high cost of bioabsorbable stents.

Bare-metal Stents
Drug-eluting Stents
Bioabsorbable Stents

By Mode of Delivery (Revenue, USD Billion):

The market is divided into self-expanding and balloon-expandable stents according to delivery method. Because of the high use of these stents, rising research initiatives to advance the technology, and rising regulatory approvals for balloon-expandable stents, the balloon expandable stents segment is anticipated to increase at the greatest CAGR over the projection period.

Balloon-expandable Stents
Self-expanding Stents

By Materials (Revenue, USD Billion):

The coronary stent market is divided into metallic (cobalt chromium, platinum chromium, nickel-titanium, and stainless steel) and other stents according to the material. The market for other stents is anticipated to experience the largest CAGR growth during the projection period. The rapid expansion of this market can be ascribed to the increased use of polymers and copolymers in the production of bioabsorbable stents.

Metallic Stents
Cobalt-Chromium
Platinum Chromium
Nickel Titanium
Stainless Steel
Other Stents

By End User (Revenue, USD Billion):

The coronary stent market is divided into hospitals, cardiac centres, and ambulatory surgical centres based on the end user. According to predictions, the hospital sector will control the market in 2016. This is primarily caused by hospitals using a lot of coronary stents.

Hospitals
Cardiac Centers
Ambulatory Surgical Centers

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.